COVID-19 Infection in Pregnancy: PCR Cycle Thresholds, Placental Pathology, and Perinatal Outcomes

Autor: María Yolotzin Valdespino-Vázquez, María de Lourdes Gómez-Sousa, Salvador Espino-Y-Sosa, Mario Solis-Paredes, Irma A. Coronado-Zarco, Juan Carlos Rodriguez-Aldama, Carolina Valencia-Contreras, Guadalupe Estrada-Gutierrez, Claudine Irles, Ricardo Figueroa-Damián, Estibalitz Laresgoiti-Servitje, Rosa Gabriela Hernández-Cruz, Manuel Cortés-Bonilla, Moisés León-Juárez, Mónica Aguinaga-Ríos, Elsa Romelia Moreno-Verduzco, Maria Antonieta Rivera-Rueda, Rafael Galván-Contreras, Jorge Arturo Cardona-Pérez, Alejandro Ortiz-Calvillo, Isabel Villegas-Mota, Addy Cecilia Helguera-Repetto, Sandra Acevedo-Gallegos, Mario Rodríguez-Bosch
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Viruses, Vol 13, Iss 1884, p 1884 (2021)
Viruses
Volume 13
Issue 9
ISSN: 1999-4915
Popis: (1) This study aimed to evaluate characteristics, perinatal outcomes, and placental pathology of pregnant women with or without SARS-CoV-2 infection in the context of maternal PCR cycle threshold (CT) values. (2) This was a retrospective case-control study in a third-level health center in Mexico City with universal screening by RT-qPCR. The association of COVID-19 manifestations, preeclampsia, and preterm birth with maternal variables and CT values were assessed by logistic regression models and decision trees. (3) Accordingly, 828 and 298 women had a negative and positive test, respectively. Of those positive, only 2.6% of them presented mild to moderate symptoms. Clinical characteristics between both groups of women were similar. No associations between CT values were found for maternal features, such as pre-gestational BMI, age, and symptomatology. A significantly higher percentage of placental fibrinoid was seen with women with low CTs (<
25
p <
0.01). Regarding perinatal outcomes, preeclampsia was found to be significantly associated with symptomatology but not with risk factors or CT values (p <
0.01, aOR = 14.72). Moreover, 88.9% of women diagnosed with COVID-19 at <
35 gestational weeks and symptomatic developed preeclampsia. (4) The data support strong guidance for pregnancies with SARS-CoV-2 infection, in particular preeclampsia and placental pathology, which need further investigation.
Databáze: OpenAIRE